Skip to main content
Log in

A Pilot Placebo-Controlled Study of Fluvoxamine for Pathological Gambling

  • Published:
Annals of Clinical Psychiatry

Abstract

The objective of this study was to evaluate the efficacy of fluvoxamine in the treatment of pathological gambling. Thirty-two patients were treated for 6 months in a double-blind, placebo-controlled study of fluvoxamine 200 mg/day. Outcome measures included reduction in money and time spent gambling per week. Longitudinal mixed effects models and completers analyses were used for estimation and hypothesis testing. Fluvoxamine was not statistically significantly different from placebo in the overall sample. However, fluvoxamine was statistically significantly superior to placebo in males and in younger patients. The power of the study was limited by the high (59%) placebo-response rate. Fluvoxamine may be a useful treatment for certain subgroups of patients with pathological gambling. Several methodological recommendations are made for future pharmacological trials of pathological gambling.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. National Research Council: Pathological Gambling: A Critical Review. Washington, DC: National Academy Press; 1999

    Google Scholar 

  2. Shaffer HJ, Hall MN, Vander BJ: Estimating the prevalence of disordered gambling behavior in the United States and Canada:Aresearch synthesis. Am J Pub Health 1999; 89:1369-1376

    Google Scholar 

  3. Lesieur HR, Rosenthal RJ: Pathological gambling: A review of the literature. J Gambling Stud 1991; 7:5-40

    Google Scholar 

  4. Hollander E, DeCaria C, Mari E, Wong CM, Mosovich S, Grossman R, Begaz T: Short-term single-blind fluvoxamine treatment of pathological gambling. Am J Psychiatry 1998; 155:1781-1783

    Google Scholar 

  5. Kim SW, Grant JE, Adson DE, Shin YC: Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling. Biol Psychiatry 2001; 49:914-921

    Google Scholar 

  6. Moreno I, Sáiz-Ruiz J, López-Ibor JJ: Serotonin and gambling dependence. Hum Psychopharmacol 1991; 6:S9-S12

    Google Scholar 

  7. DeCaria CM, Hollander E, Grossman R: Diagnosis, neurobiology and treatment of pathological gambling. J Clin Psychiatry 1996; 57(Suppl 8):80-84

    Google Scholar 

  8. Blanco C, Oresanz-Muñoz L, Blanco-Jerez C, Sáiz-Ruiz J: Pathological gambling and platelet MAO activity: Apsychobiological study. Am J Psychiatry 1996; 153:119-121

    Google Scholar 

  9. Pérez de Castro I, Ibáñez A, Sáiz-Ruiz J, Fernández-Piquereras J: Genetic contribution to pathological gambling: Association between a functional DNA polymorphism at the serotonin transporter gene (5-HTT) and affected males. Pharmacogenetics 1999; 9:397-400

    Google Scholar 

  10. Potenza MN, Steinberg MA, McLaughlin SD, Wu R, Rounsaville BJ, O'Malley SS: Gender differences in the characteristics of problems gamblers using a gambling helpline. Am J Psychiatry 2001; 158:1500-1505

    Google Scholar 

  11. Tavares H, Zilberman ML, Beites FJ, Gentil V: Gender differences in gambling progression. J Gambling Stud 2001; 17:151-159

    Google Scholar 

  12. Hollander E, DeCaria C, Finkell JN, Begaz T, Wong CM, Cartwright C: A randomized double-blind fluvoxamine/ placebo crossover trial in pathological gambling. Biol Psychiatry 2000; 47:813-817

    Google Scholar 

  13. Laird NM, Ware JH: Random effects models for longitudinal data. Biometrics 1982; 38:963-974

    Google Scholar 

  14. Diggle PJ, Liang K-Y, Zeger SL: Analysis of Longitudinal Data. Oxford: Clarendon; 1994

    Google Scholar 

  15. Haller R, Hinterhuber H: Treatment of pathological gambling with carbamazepine. Pharmacopsychiatry 1994; 27: 129

    Google Scholar 

  16. Hollander E, Frankel M, DeCaria C, Trungold S, Stein DJ: Treatment of pathological gambling with clomipramine. Am J Psychiatry 1992; 149:710-711

    Google Scholar 

  17. Ricca V, Mannucci E, Mezzani B, Moretti S, Di Bernardo M, Bertelli M, Rotella CM, Favarelli C: Psychother Psychosom 2001; 70:298-306

    Google Scholar 

  18. Hollander E: Obsessive-Compulsive Related Disorders. Washington, DC: American Psychiatric Press; 1993

    Google Scholar 

  19. Kim SW, Grant JE: Personality dimensions in pathological gambling disorder and obsessive-compulsive disorder. Psychiatry Res 2001; 104:205-212

    Google Scholar 

  20. Blanco C, Moreyra P, Nunes EV, Saiz-Ruiz J, Ibáñez A: Pathological gambling: Addiction or compulsion? Semin Clin Neuropsychiatry 2001; 6:167-176

    Google Scholar 

  21. Sylvain C, Ladouceur R, Boisvert JM: Cognitive and behavioral treatment of pathological gambling: A controlled study. J Consult Clinl Psychol 1997; 65:727-732

    Google Scholar 

  22. Miller RW, Rollnick S: Motivational Interviewing: Preparing People to Change Addictive Behavior. New York: Guilford; 1991

    Google Scholar 

  23. Galanter M: Network Therapy for Alcohol and Drug Abuse: A new Approach in Practice. New York: Basic Books; 1993

    Google Scholar 

  24. Nunes EV: Methodologic recommendations for cocaine abuse clinical trials: A clinician-researcher's perspective. NIDA Res Monogr 1997; 175:73-95

    Google Scholar 

  25. Ibáñez A, Pérez de Castro I, Fernández-Piqueras J, Sáiz-Ruiz J: Sex differences in genetic contribution to pathological gambling. Am J Med Gen 1998; 81:523

    Google Scholar 

  26. Lesieur HR, Blume SB: When lady luck loses: The female pathological gambler. In: Van den BN, ed. Feminist Perspectives on Addictions. New York: Springer; 1991

    Google Scholar 

  27. McCormick RA, Russo AM, Ramírez LF, Taber JI: Affective disordersamongpathological gamblers seeking treatment. Am J Psychiatry 1984; 141:215-218

    Google Scholar 

  28. Roy A, Adinoff B, Roehrich L, Lamparski D, Custer R, Lorenz V, Barabaccia M, Guidotti A, Costa E, Linnoila M: Pathological gambling: A psychobiological study. Arch Gen Psychiatry 1988; 45:369-373

    Google Scholar 

  29. Bergh C, Eklund T, Sodersten P, Nordin C: Altered dopamine function in pathological gambling. Psychol Med 1997; 27:473-475

    Google Scholar 

  30. Roose SP, Suthers KM: Antidepressant response in late-life depression. J Clin Psychiatry 1998; 59(Suppl 10):4-8

    Google Scholar 

  31. Brown RIF: Classical and operant paradigms in the managament of gambling addictions. Behav Psychother 1987; 15:111-122

    Google Scholar 

  32. Brown RIF, Stewart RM: An outcome study of Gamblers Anonymous. Br J Psychiatry 1988; 152:284-288

    Google Scholar 

  33. Kelpsch R, Hand I, Wlazlo Z: Long-term effects of multimodal behavior therapy for pathological gamblers. Suchgefahren 1989; 35:35-49

    Google Scholar 

  34. Moskowitz JA: Lithium and lady luck: Use of lithium carbonate in compulsive gambling. NYS J Med 1980; 80:785-788

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Blanco, C., Petkova, E., Ibáñez, A. et al. A Pilot Placebo-Controlled Study of Fluvoxamine for Pathological Gambling. Ann Clin Psychiatry 14, 9–15 (2002). https://doi.org/10.1023/A:1015215809770

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1015215809770

Navigation